Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amyris
Amyris
Amyris to buy women’s wellness firm MenoLabs
Amyris to buy women’s wellness firm MenoLabs
Pharmaceutical Business Review
Amyris
MenoLabs
menopause
M&A
Women's Health
Flag link:
Is Amyris Finally Turning a Corner?
Is Amyris Finally Turning a Corner?
Motley Fool
Amyris
earnings
synthetic biology
Flag link:
Amyris Is Spending Way Too Much on Manufacturing Costs
Amyris Is Spending Way Too Much on Manufacturing Costs
Motley Fool
Amyris
synthetic biology
drug manufacturing
Flag link:
Can Amyris Succeed With Its Latest Turnaround?
Can Amyris Succeed With Its Latest Turnaround?
Motley Fool
Amyris
Flag link:
Why Amyris Plummeted 26% in March
Why Amyris Plummeted 26% in March
Motley Fool
Amyris
Flag link:
Amyris Finally Turns A Corner And Not A Quarter Too Soon
Amyris Finally Turns A Corner And Not A Quarter Too Soon
Seeking Alpha
Amyris
Flag link:
This Next-Generation Biotech Just Set the Stage for a Big 2015
This Next-Generation Biotech Just Set the Stage for a Big 2015
Motley Fool
biotech
Amyris
Flag link:
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Amyris, Inc. To Contact The Firm
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Amyris, Inc. To Contact The Firm
Yahoo/PRNewswire
stock
investors
investment
Amyris
legal
Flag link:
Bronstein, Gewirtz & Grossman, LLC Announces That A Class Action Has Been Filed Against Amyris, Inc.
Bronstein, Gewirtz & Grossman, LLC Announces That A Class Action Has Been Filed Against Amyris, Inc.
Yahoo/PR Newswire
Amyris
lawsuits
Flag link:
Amyris rises on Sanofi malaria drug news
Amyris rises on Sanofi malaria drug news
Yahoo/AP
artemisinin
Amyris
malaria
Sanofi
Flag link:
Amyris Advances Most in Two Weeks After Reporting Narrower Loss
Amyris Advances Most in Two Weeks After Reporting Narrower Loss
Bloomberg
Amyris
Flag link:
Hedge Funds Are Buying These 10 High-Growth Biotech Stocks
Hedge Funds Are Buying These 10 High-Growth Biotech Stocks
Seeking Alpha
Xoma
Jazz Pharmaceuticals
Pacific Biosciences
Amylin
Corcept Therapeutics
Santarus
Affymetrix
Ariad Pharmaceuticals
Amyris
Sequenom
Flag link:
10 Biotech Stocks Positively Correlated To Volatility
10 Biotech Stocks Positively Correlated To Volatility
Seeking Alpha
Amyris
Aveo
China Biologic
Chelsea Therapeutics
Pluristem
Spectrum Pharmaceuticals
Questcor
Theravance
Vical
Zalicus
Flag link:
Amyris Misses on the Top and Bottom Lines
Amyris Misses on the Top and Bottom Lines
Yahoo/AP
Amyris
earnings
Flag link:
Amyris Finds Scaling Up More Difficult Than Expected
Amyris Finds Scaling Up More Difficult Than Expected
Seeking Alpha
Amyris
Flag link:
3 Highly Shorted Biotech Stocks Being Bought Up By Hedge Funds
3 Highly Shorted Biotech Stocks Being Bought Up By Hedge Funds
Seeking Alpha
Vivus
Seattle Genetics
Amyris
Flag link:
Amyris shares tumble on outlook
Amyris shares tumble on outlook
Yahoo/AP
Amyris
Flag link:
8 Underperforming Biotech Stocks Being Bought by the Smart Money
8 Underperforming Biotech Stocks Being Bought by the Smart Money
Seeking Alpha
Amyris
NPS Pharmaceuticals
Targacept
Sequenom
Cadence Pharmaceuticals
Enzon
Dendreon
Incyte
Flag link:
7 Highly Liquid, Low Debt Biotech Stocks Seeing Smart Money Buys
7 Highly Liquid, Low Debt Biotech Stocks Seeing Smart Money Buys
Seeking Alpha
Optimer
Amyris
Sequenom
Immunogen
Pacific Biosciences
3SBio
Cadence Pharmaceuticals
Flag link:
Amyris Shares Popped: What You Need to Know
Amyris Shares Popped: What You Need to Know
Motley Fool
Amyris
Flag link:
Pages
1
2
next ›
last »